Dr Viviana Marzaioli is a Principal Investigator within the Molecular Rheumatology group in the Trinity Biomedical Sciences Institute (TCD). Her research focuses on investigating the contribution of innate immunity in the initiation and the progression of Rheumatoid and Psoriatic arthritis, with an emphasis on the dysregulation in monocyte-derived cells development. Her research goal is to identify underlying mechanisms involved in driving disease-specific pathogenesis in RA and PsA, for the development of stratified therapeutical approaches for patients.
Dr Marzaioli has been awarded and received independent fundings, including the prestigious Newman Research Fellowship in Rheumatology in 2019 (Centre for Arthritis and Rheumatic Diseases) and the SFI-IRC Pathway Programme for emerging independent researchers in 2022 (Molecular Rheumatology, TCD).
As part of the Molecular Rheumatology group, Dr Marzaioli works closely with Arthritis Ireland and CARD charity organizations, and she has strong collaborations with industrial partners for the future development of preclinical proof of concept studies. She is involved in “Patient and Public involvement” activities, with the aim to integrate patients’ perspective into research and to develop a stronger patients-focused scientific studies.